CAS: 4068-78-4; Methyl 5-Chloro-2-Hydroxybenzoate

该化合物是一种合成有机化合物,分子式为C8H7ClO3.它是硅酸的衍生物,在5位置有一个氯替代物,在碳箱基位置有一个甲基酯组.由于其反应性氢氧基和酯的功能,该化合物通常用作制药和农用化学合成的中间体.其结构特性使得其进一步功能化,使其对生产活性成分或特殊化学物具有价值.氯和氢氧化物组有助于其交叉组合反应或作为复杂分子的前体的用途.由于它具有潜在的再活动性,它通常在受控制的条件下处理.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号321-14-2 5-氯代水杨酸 | CAS号67-56-1 甲醇 | CAS号119-36-8 水杨酸甲酯 | CAS号75-36-5 乙酰氯 | CAS号74-88-4 碘甲烷 | CAS号1126-46-1 甲基-4-氯苯甲酸甲酯 | CAS号69-72-7 水杨酸 | CAS号16487-46-0 methyl N,N-dich... | CAS号76-06-2 氯化苦 | CAS号3261-05-0 5-氯苯并呋喃-3(2H)-酮 | CAS号439117-38-1 5-氯-2-氰基苯甲酸甲酯 | CAS号141762-02-9 3,4-二氢-4-甲基-3-氧... | CAS号5043-81-2 3-氨基-5-氯-2-羟基苯甲酸甲酯 | CAS号5022-48-0 5-氯-2-羟基苯甲酰肼 | CAS号197504-51-1 6-氯-4-羟基-3-甲基-2... | CAS号20324-50-9 5-氯-2-巯基苯甲酸 | CAS号189308-64-3 5-chloro-2,2-di... | CAS号5330-38-1 5-氯-2-羟基苯甲醇 | CAS号7120-43-6 5-氯水杨酰胺

合成工艺路线路线简述

    水杨酸甲酯 以 氯仿 作为反应溶剂,以152 G (81.5%)的收率获得产物5-氯-2-羟基苯甲酸甲酯
    参考文献:Halo-Containing 3-Methylflavone-8-Carboxylic Acid Derivatives
    标题:Halo-Containing 3-Methylflavone-8-Carboxylic Acid Derivatives
    摘要:这项发明涉及由式(1)表示的3-甲基黄酮-8-羧酸衍生物 ##str1## 其中r代表氢原子,较低的烷基基团或基团 ##str2## (其中r.Sup.1和r.Sup.2代表较低的烷基基团或r.Sup.1和r.Sup.2,当与它们连接的氮原子一起时,可以形成具有或不具有介入杂原子的杂环环,N为1至4的整数),X代表卤原子,这些衍生物可用作中间体.这项发明还涉及制备这些衍生物的方法.

    海关参考信息

    专利信息


    专利号:US-H1406-H
    优先权日:1993-04-30
    标题:Process for preparing dibenzofurans via catalytic heteroannulation
    发明人:POWERS MATTHEW R
    权利人:RHONE POULENC RORER PHARMA
    摘要:The present invention is directed to the synthesis of 2-chloro-cis-[5a(S)-9a(S)-(5a,6,7,8,9,9a-hexahydro)]dibenzofuran-4-carboxylic acid by a stereospecific catalytic heteroannulation synthesis free of undesirable 8-chloro-2,6-methano-2H-3,4,5,6-tetrahydro-1-benzoxocin-10-carboxylic.

    专利号:US-5278323-A
    优先权日:1993-04-30
    标 题 :Process for preparing chiral dibenzofurans via intramolecular heck reaction
    发明人:POWERS MATTHEW R
    权利人:RHONE POULENC RORER PHARMA
    摘要:The present invention is directed to the synthesis of 2-chloro-cis-[5a(S)-9a(S)-(5a,6,7,8,9,9a-hexahydro)]dibenzofuran-4-carboxylic acid by an intramolecular Heck stereospecific synthesis substantially free of undesirable 8-chloro-2,6-methano-2H-3,4,5,6-tetrahydro-1-benzoxocin-10-carboxylic.

    专利号:RU-2411234-C2
    优先权日:2004-12-16
    标题 :Method for synthesis of n-substituted salicylamides

    专利号:US-2012053165-A1
    优先权日:2009-03-03
    标 题:Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
    发明人:ALLEN MARTIN PATRICK; AM ENDE CHRISTOPHER WILLIAM; BRODNEY MICHAEL AARON; DOUNAY AMY BETH; JOHNSON DOUGLAS SCOTT; PETTERSSON MARTIN YOUNGJIN; SCHWARTZ JACOB BRADLEY; TRAN TUAN PHONG
    权利人:ALLEN MARTIN PATRICK; AM ENDE CHRISTOPHER WILLIAM; BRODNEY MICHAEL AARON; DOUNAY AMY BETH; JOHNSON DOUGLAS SCOTT; PETTERSSON MARTIN YOUNGJIN; SCHWARTZ JACOB BRADLEY; TRAN TUAN PHONG; PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-9067934-B2
    优先权日:2011-03-31
    标题 :Bicyclic pyridinones
    发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; FISH BENJAMIN ADAM; GREEN MICHAEL ERIC; MULLINS PATRICK BRADLEY; STIFF CORY MICHAEL; TRAN TUAN PHONG; NAVARATNAM THAYALAN
    权利人:PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:US-2012202787-A1
    优先权日:2009-10-20
    标 题:Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
    发明人:AM ENDE CHRISTOPHER WILLIAM; JOHNSON DOUGLAS SCOTT; PETTERSSON MARTIN YOUNGJIN; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN
    权利人:AM ENDE CHRISTOPHER WILLIAM; JOHNSON DOUGLAS SCOTT; PETTERSSON MARTIN YOUNGJIN; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; PFIZER
    摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; n n n n n n n n n n as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    浙江海昇药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: https://www.zcpc.net/
    企业联系电话:0570-8750611;8750616;8750618;8750620;8750500-8055👤
    📞浙江海昇药业股份有限公司 ⚠️参考联系方式
    联系人:张琳;崔霞霞;陈一晟;周逸君
    电话:0570-8750611;8750616;8750618;8750620;8750500-8055
    手机:13357006799;15317109187;18868105702;18805706626
    传真:0570-8750617
    邮箱:zhl@zcpc.net;cxx@zcpc.net;eason@zcpc.net;Steve@zcpc.net
    通信地址: 浙江省衢州市高新技术产业园区华阳路36号
    邮编: 324000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省衢州市高新技术产业园区华阳路36号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Gao, W.-C.; Tian, J., Science of Synthesis Knowledge Updates, (2020) 3, 289.
    摘要:Stanforth, S. P., Science of Synthesis Knowledge Updates, (2015) 1, 175.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知